Prognostic biomarkers will detect lung cancer at earlier stages

E-hospital: Fully coordinated cancer care and research in Europe

Combination of capecitabine and bevacizumab improves progression-free survival in metastatic breast cancer

Research shows chemotherapy has no negative effects on babies in utero

Helping cancer patients make sense of risk

Reducing nausea and vomiting associated with cisplatin-based chemotherapy with rolapitant

The evolving treatment landscape for HER2-positive metastatic breast cancer

Navigating current treatment options for HER2-positive MBC: Patient journey 1

Emerging treatments in CLL: Expert Discussion

WIN consortium as a basis for forming cross-border collaborations for improving personalised medicine and palliative care

Does the use of generics of imatinib for chronic myeloid leukaemia jeopardise patient safety?

Use of GA101 and Clb preferable to rituximab in elderly or unfit chronic lymphocytic leukaemia patients